toggle

Juno Therapeutics Inc

Latest Juno Therapeutics Inc News and Updates

Company & Industry Overviews
What Else Could Drive Gilead’s Long-Term Growth?
In December 2017, Kite, a Gilead Sciences (GILD) company, presented long-term follow-up data from its pivotal ZUMA-1 trial of Yescarta.
By Daniel CollinsNov. 20 2020, Updated 12:27 p.m. ET
Company & Industry Overviews
Celgene to Acquire Juno Therapeutics
On January 22, 2018, Celgene and Juno Therapeutics announced a merger agreement in which the former will acquire the latter’s business.
By Daniel CollinsJan. 24 2018, Published 11:32 a.m. ET

ABOUT Market Realist
About Us
Privacy Policy
Terms of Use
DMCA

CONNECT with Market Realist

© Copyright 2024 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.

Juno Therapeutics Inc

What Else Could Drive Gilead’s Long-Term Growth?

Celgene to Acquire Juno Therapeutics